IGF1 – LR3

290 AED

an extended version of the insulin-like factor growth activates tissue hyperplasia and persists in the blood 120 times longer than the original.

SKU: peptide-igf1-lr3 Category:

Description

IGF-1 LR3 is an engineered peptide developed for long—term stimulation of cell growth. Due to its amino acid substitution and elongated structure, it does not bind to IGF inhibitor proteins and remains active in the bloodstream throughout the day. this gives a pronounced anabolic effect: it is not the volume of cells that increases, but their number — hyperplasia. muscles, bones, blood vessels, skin, liver — all tissues sensitive to igf-1 receive a steady signal for regeneration, recovery and functional growth. without sudden hormone surges and without excessive stress on the receptors.

IGF-1 LR3 in ampoule format is a high-concentration extended-release peptide used in protocols requiring intensive anabolic and regenerative support. Its enhanced molecular stability provides prolonged IGF receptor stimulation and faster tissue regeneration under conditions of increased physical load.

The peptide activates protein synthesis, improves the repair of tendons, fascia, and muscle fibers, and contributes to overall improvements in body composition. IGF-1 LR3 supports fat reduction while maintaining functional strength, helping achieve more defined muscle contour.

The ampoule format is preferred when a powerful and rapid anabolic response is needed, especially during high-intensity training phases, post-exercise recovery, or periods requiring accelerated adaptation.

IGF-1 LR3 Ampoule is suitable for individuals seeking a pronounced boost in muscle growth, improved recovery dynamics, and enhanced performance efficiency. This format is particularly relevant for athletic protocols, performance systems, and high-demand training cycles.

Additional information

Dosage

0,1 mg

Reviews

There are no reviews yet.

Be the first to review “IGF1 – LR3”

Your email address will not be published. Required fields are marked *